Free Trial

Natera (NTRA) Competitors

Natera logo
$140.12 +3.55 (+2.60%)
Closing price 08/5/2025 04:00 PM Eastern
Extended Trading
$141.25 +1.13 (+0.81%)
As of 08/5/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NTRA vs. FMS, HIMS, GH, OPCH, RDNT, BTSG, SHC, SGRY, CON, and WGS

Should you be buying Natera stock or one of its competitors? The main competitors of Natera include Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and GeneDx (WGS). These companies are all part of the "healthcare" industry.

Natera vs. Its Competitors

Natera (NASDAQ:NTRA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Fresenius Medical Care AG & Co. KGaA has a net margin of 3.18% compared to Natera's net margin of -10.36%. Fresenius Medical Care AG & Co. KGaA's return on equity of 6.25% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-10.36% -18.29% -11.68%
Fresenius Medical Care AG & Co. KGaA 3.18%6.25%2.88%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$1.70B11.28-$190.43M-$1.47-95.32
Fresenius Medical Care AG & Co. KGaA$20.63BN/A$582.08M$1.1221.78

Natera presently has a consensus price target of $183.76, indicating a potential upside of 31.15%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $27.80, indicating a potential upside of 13.98%. Given Natera's stronger consensus rating and higher probable upside, analysts plainly believe Natera is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
3.06
Fresenius Medical Care AG & Co. KGaA
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Natera had 27 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 30 mentions for Natera and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 0.82 beat Fresenius Medical Care AG & Co. KGaA's score of 0.80 indicating that Natera is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
17 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Natera has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 16 factors compared between the two stocks.

Get Natera News Delivered to You Automatically

Sign up to receive the latest news and ratings for NTRA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NTRA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NTRA vs. The Competition

MetricNateraMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$18.65B$7.17B$5.59B$9.53B
Dividend YieldN/A2.87%4.73%4.14%
P/E Ratio-95.3265.8528.9123.88
Price / Sales11.2830.36445.9598.82
Price / CashN/A26.2535.6858.35
Price / Book15.488.758.165.60
Net Income-$190.43M$239.96M$3.25B$265.26M
7 Day Performance-0.60%-0.54%1.16%-0.14%
1 Month Performance-13.24%-2.31%8.26%6.08%
1 Year Performance38.84%24.58%29.19%24.22%

Natera Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NTRA
Natera
3.5836 of 5 stars
$140.12
+2.6%
$183.76
+31.1%
+43.1%$18.65B$1.70B-95.324,434Upcoming Earnings
Insider Trade
FMS
Fresenius Medical Care AG & Co. KGaA
3.7046 of 5 stars
$25.86
-2.2%
$27.80
+7.5%
+29.9%$15.18B$19.49B23.091,384News Coverage
HIMS
Hims & Hers Health
2.5522 of 5 stars
$58.67
+1.8%
$39.83
-32.1%
+211.2%$13.13B$1.48B85.031,637Trending News
Earnings Report
Analyst Forecast
Gap Down
GH
Guardant Health
3.4925 of 5 stars
$44.27
-0.3%
$54.45
+23.0%
+51.1%$5.48B$739.02M-13.062,021Earnings Report
OPCH
Option Care Health
4.6195 of 5 stars
$29.77
+0.3%
$35.50
+19.2%
-5.4%$4.87B$5.00B24.018,088News Coverage
Earnings Report
Analyst Revision
RDNT
RadNet
4.0783 of 5 stars
$57.83
+0.7%
$69.60
+20.4%
+0.3%$4.34B$1.83B-134.4911,021Positive News
Upcoming Earnings
BTSG
BrightSpring Health Services
2.9365 of 5 stars
$20.48
-0.2%
$24.90
+21.6%
+77.7%$3.60B$11.27B73.1435,000Earnings Report
SHC
Sotera Health
1.8909 of 5 stars
$12.29
-0.1%
$16.00
+30.2%
-21.3%$3.49B$1.10B153.643,000
SGRY
Surgery Partners
2.7699 of 5 stars
$22.44
+5.6%
$33.33
+48.5%
-22.9%$2.88B$3.17B-14.6715,000News Coverage
Positive News
Gap Up
CON
Concentra Group Holdings Parent
2.8762 of 5 stars
$20.05
+2.0%
$28.50
+42.1%
-11.0%$2.57B$1.93B14.9611,250Upcoming Earnings
WGS
GeneDx
3.0473 of 5 stars
$84.91
+6.4%
$92.33
+8.7%
+278.4%$2.42B$305.45M-60.221,200Earnings Report
Analyst Upgrade

Related Companies and Tools


This page (NASDAQ:NTRA) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners